Psychological insulin resistance: The patient perspective

Diabetes Educator

Volumn 33, Issue SUPPL. 7, 2007, Pages

  Polonsky, William ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Roche Diagnostics ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; ATTITUDE TO HEALTH; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE;

EID: 34547670266     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721707305701     Document Type: Article

References (19)

1. Peyrot M., Rubin RR, Lauritzen T., et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005 ; 28: 2673-2679.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998 ; 352: 837-854.
3. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000 ; 321: 405-412.
4. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998 ; 317: 703-713.
5. Gaede P., Vedel P., Larsen N., Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003 ; 348: 383-393.
6. Donnan PT, MacDonald TM, Morris AD Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002 ; 19: 279-284.
7. Paes AH, Bakker A., Soe-Agnie CJ Impact of dosage frequency on patient compliance. Diabetes Care. 1997 ; 20: 1512-1517.
8. Polonsky WH, Fisher L., Guzman S., Villa-Caballero L., Edelman SV Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 ; 28: 2543-2545.
9. Polonsky WH, Fisher L., Dowe S., Edelman S. Why do patients resist insulin therapy? [abstract]. Diabetes. 2003 ; 52: A417.
10. Skovlund SE, van der Ven N., Pouwer F., Snoek F. Appraisal of insulin treatment in type 2 diabetes patients with and without previous experience of insulin therapy [abstract]. Diabetes. 2003: 52: A419.
11. Polonsky WH, Jackson RA What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004 ; 22: 147-150.
12. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004 ; 27: 1535-1540.
13. Riddle MC Timely addition of insulin to oral therapy for type 2 diabetes. Diabetes Care. 2002 ; 25: 395-396.
14. Haque M., Emerson SH, Dennison CR, Navsa M., Levitt NS Barriers to initiating insulin therapy in patients with type 2 diabetes in public-sector primary health care centres in Cape Town. S Afr Med J. 2005 ; 95: 798-802.
15. Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ. 2004 ; 30: 274-280.
16. Riddle MC, Rosenstock J., Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003 ; 26: 3080-3086.
17. Rosenstock J., Sugimoto D., Strange P., Stewart JA, Soltes-Rak E., Dailey G. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care. 2006 ; 29: 554-559.
18. Halter JB, Kennedy L., Herman WH, Miller MF Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): the GOAL A1C Study. Abstracts of the 66th Scientific Sessions of the ADA. Diabetes. 2006 ;55(suppl 1):A114. Abstract 480-P.
19. Zarate R., Agras WS Psychosocial treatment of phobia and panic disorders. Psychiatry. 1994 ; 57: 133-141.